DNAPrint Genomics Overview
- Founded
-
1983
- Status
-
Public
- Employees
-
24
- Stock Symbol
-
DNAG
- Investments
-
1
DNAPrint Genomics General Information
Description
DNA Print Genomics Inc is a pharmaceutical company that focuses on the human genome sciences. Through its subsidiaries, it is into research and development of genomic products and provides scientific services and tests to the genealogy, forensic, pharmaceutical, and genetics markets; and focuses on personalized medicine; and other operations.
Contact Information
Formerly Known As
Lexington Energy
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Laboratory Services (Healthcare)
Stock Exchange
GREY
Primary Office
- 1621 West University Parkway
- Sarasota, FL 34243
- United States
+1 (941) 000-0000
DNAPrint Genomics Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 8.73K |
DNAPrint Genomics Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2007 | FY 2006 31-Dec-2006 | FY 2005 31-Dec-2005 | FY 2004 31-Dec-2004 |
|---|---|---|---|---|
| EV | 8,275 | |||
| Revenue | 1,931 | 2,433 | 1,276 | 786 |
| Net Income | (4,551) | (12,348) | (8,716) | (3,735) |
| Total Assets | 3,113 | 10,270 | 6,310 | 1,791 |
| Total Debt | 5,328 | 7,283 | 1,070 | 628 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
DNAPrint Genomics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
DNAPrint Genomics Patents
DNAPrint Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20080027756-A1 | Systems and methods for identifying and tracking individuals | Inactive | 30-Jun-2006 | 000000000 | |
| AU-2006214039-A1 | Multiplex assays for inferring ancestry | Inactive | 18-Feb-2005 | 0000000000 | |
| CA-2598455-A1 | Multiplex assays for inferring ancestry | Inactive | 18-Feb-2005 | 0000000000 | |
| EP-1853730-A2 | Multiplex assays for inferring ancestry | Inactive | 18-Feb-2005 | 0000000000 | |
| AU-2005304645-A1 | Compositions and methods for inferring an adverse effect in response to a drug treatment | Inactive | 12-Nov-2004 | C12Q1/6883 |
DNAPrint Genomics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
DNAPrint Genomics Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000000 ( | 04-Nov-2004 | 00000 0000 | 000.00 | Pharmaceuticals |
DNAPrint Genomics Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000000000 (00000 | 04-Nov-2004 | 00000 00000 00 | 000.00 | Completed |
|